Infectious Disease

Redfort RCMSpecialtiesInfectious Disease
Acupuncture
Ambulatory Surgery Centers (ASCs)
Anesthesiology
Cardiology
Chiropractic
Dentistry
Dermatology
DME
Emergency Medicine
Endocrinology
Family Practice
Gastroenterology
General Surgery
Geriatrics
Hematology
Hepatology
Internal Medicine
Laboratory Billing
Molecular Lab
Nephrology
Neurosurgery
Nursing & Skilled Nursing
OBGYN
Oncology
Ophthalmology
Pain Management
Pathology Lab
Pediatrics
Physical Therapy
Podiatry
Primary Care
Prosthetics
Psychiatry
Psychology
Pulmonology
Radiology
Speech Therapy
TeleMedicine
Thoracic Surgery
Toxicology Lab
Home Health
Home Nursing
Immunology
Infectious Disease
Traumatology
Urology
Rheumatology
Preventive Medicine
Medical Genetics & Genomics
Addiction Medicine
Addiction Psychiatry
Otolaryngology / ENT
Plastic Surgery
Vascular Surgery
Colon & Rectal Surgery
Orthopedics / Orthopaedic Surgery
Physical Medicine & Rehab
Sports Medicine
Interventional Pain Management
Interventional Radiology
Radiation Oncology
Occupational Therapy
Audiology
Infectious Disease
Complex Infections Require Precise Reimbursement Strategy.

The Infectious Disease Revenue Reality

Infectious disease care is high-complexity and documentation-intensive. Unlike procedure-driven specialties, infectious disease revenue often depends on accurate documentation of medical complexity and time-based services. Small documentation inconsistencies can trigger full claim denials.

  • Consult and E/M downcoding
  • Prolonged service misclassification
  • Hospital-to-outpatient billing misalignment
  • IV antibiotic and antiviral infusion denials
  • J-code unit errors
  • Medical necessity disputes
  • Modifier sequencing errors
  • High-dollar AR tied to infusion therapies

Consult & Time-Based Coding Precision (CCP)

  • E/M documentation alignment
  • Prolonged service coding accuracy
  • Complexity documentation support
  • Modifier governance
  • Add-on code integrity checks

Target Outcome: Reduced downcoding and improved first-pass acceptance.

Infusion & Specialty Drug Controls (CCP + EAE)

  • J-code unit validation
  • Infusion time compliance
  • Diagnosis-to-drug alignment
  • Prior authorization verification

Target Outcome: Fewer infusion and antiviral reimbursement rejections.

Inpatient & Outpatient Coordination Controls (FIO + AAF)

  • Coverage validation across settings
  • Hospital discharge follow-up billing checks
  • Structured AR triage for high-value cases
  • AR > 90 monitoring by therapy category

Target Outcome: Improved reimbursement continuity across transitions of care.

Complexity & Payer Pattern Intelligence (PRL)

  • E/M downcoding trends by payer
  • Infusion reimbursement variance
  • Denial clustering by diagnosis category
  • AR aging concentration by service type

Target Outcome: Visibility into recurring consult and infusion-related revenue leakage.

Measurable Performance Targets

  • 8–18% lift in net collections
  • 15–30% reduction in denial and downcoding rates
  • 25–40% reduction in AR > 90
  • 95–98% first-pass claim acceptance
  • Faster appeal resolution cycles

Compliance & Infrastructure

  • HIPAA-compliant workflows with BAA signed prior to PHI exchange
  • Integration with major EHR platforms including Epic, Cerner, Athenahealth, NextGen, eClinicalWorks and others
  • Cybersecurity oversight via Redfort Technologies
  • U.S.-based nationwide operations

Are Your Consult and Infusion Claims Being Downcoded or Denied Due to Documentation Gaps?

Schedule a specialized Infectious Disease Revenue Audit and identify how coding accuracy, documentation gaps, and denial patterns are affecting your claims, AR performance, and net collections.

Schedule a FREE Audit Now